Berlin, Germany

Günter Neef

This inventor holds 6 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Günter Neef. Retrieved from https://idiyas.com/inventor/ganduumlnter-neef

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Günter Neef: Innovator in Vitamin D Derivatives

Introduction

Günter Neef is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of Vitamin D derivatives. With a total of 6 patents to his name, Neef's work has had a considerable impact on pharmaceutical advancements.

Latest Patents

Among his latest patents, Neef has focused on Vitamin D derivatives with carbo- or heterocyclic substituents at C-25. His patents detail a process for their production, intermediate products, and their use in producing medicaments. This innovative approach has the potential to enhance the efficacy of pharmaceutical agents derived from Vitamin D.

Career Highlights

Throughout his career, Neef has worked with prominent companies, including Schering Aktiengesellschaft. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to drive innovation in medicinal chemistry.

Collaborations

Neef has collaborated with esteemed colleagues such as Andreas Steinmeyer and Gerald Kirsch. These partnerships have fostered a collaborative environment that has contributed to the success of his research and inventions.

Conclusion

Günter Neef's contributions to the field of medicinal chemistry, particularly through his patents on Vitamin D derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…